相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
M. Neovius et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
Martin Neovius et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
D. Salmon-Ceron et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009
M. Neovius et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
No Evidence of Association Between Anti-Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis Results From the British Society for Rheumatology Biologics Register
Mark Lunt et al.
ARTHRITIS AND RHEUMATISM (2010)
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
J. P. Leombruno et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?
Johan Askling et al.
ARTHRITIS AND RHEUMATISM (2009)
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-α Agents
Anja Strangfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry
M. L. Hetland et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
Loreto Carmona et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
Lennart T. H. Jacobsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Comparison of dynamic treatment regimes via inverse probability weighting
MA Hernán et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Swedish registers to examine drug safety and clinical issues in RA
J Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
J Askling et al.
ARTHRITIS AND RHEUMATISM (2005)
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
AK Mohan et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
分享论文
